TD Cowen cuts Surgery Partners stock target, retains Buy on outcomes
| SGRY Stock | USD 21.08 0.21 0.99% |
Slightly above 61% of Surgery Partners' investor base is looking to short. The analysis of overall sentiment of trading Surgery Partners stock suggests that many investors are alarmed at this time. Surgery Partners' investing sentiment can be driven by a variety of factors including economic data, Surgery Partners' earnings reports, geopolitical events, and overall market trends.
Surgery |
TD Cowen cuts Surgery Partners stock target, retains Buy on outcomes
Read at investing.com
 |
Surgery Partners Fundamental Analysis
We analyze Surgery Partners' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgery Partners using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgery Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Surgery Partners is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Surgery Partners Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Surgery Partners stock to make a market-neutral strategy. Peer analysis of Surgery Partners could also be used in its relative valuation, which is a method of valuing Surgery Partners by comparing valuation metrics with similar companies.
Peers
Surgery Partners Related Equities
| HCSG | Healthcare Services | 2.62 | ||||
| EHAB | Enhabit | 1.55 | ||||
| INNV | InnovAge Holding | 1.02 | ||||
| NHC | National HealthCare | 0.30 | ||||
| PNTG | Pennant | 0.30 | ||||
| ADUS | Addus HomeCare | 0.27 | ||||
| ENSG | Ensign | 0.28 | ||||
| UHS | Universal Health | 0.43 | ||||
| EHC | Encompass Health | 0.73 | ||||
| SEM | Select Medical | 2.08 | ||||
| CCM | Concord Medical | 30.23 |
Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.